Comments Off on Study on New Combination of Immunotherapy Shows Promising Lung Cancer Treatment
In a recent study, researchers have established that a novel combination of two forms of immunotherapy can be highly effective in treatment of lung cancer. [...]
Comments Off on Lovelace Biomedical Provides New Formulation for Lung Cancer Treatment
Lung Cancer is a deadly disease taking away lives of hundreds of people every year. More and more studies and researches are being conducted in the arena for [...]
Comments Off on Moffitt Researchers Develop Tool to Predict Lung Cancer Treatment
Choosing the right therapy for non-small cell lung cancer patient is not always an easy decision. Biomarkers can change during the therapy, making that [...]
Comments Off on New Study Identifies Drug to Boost Lung Cancer Survival Rates
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is [...]
Comments Off on New EarlyCDT-Lung Blood Test for Early Detection of Lung Cancer
Thanks to the pioneering new blood test, lung cancer could be detected earlier. This news comes as a fresh hope for lung cancer patients. The main reason [...]
Comments Off on Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]
Comments Off on FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]
Comments Off on What to Consider Before Getting A Lung Cancer on Marijuana Medication?
Lung cancer is one of the major causes of death, particularly in the US. It has been found that more people die because of it as compared to other types of [...]
Comments Off on Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. [...]
Comments Off on Lung Cancer Awareness Month: Latest Researches in Lung Cancer Treatment
Lung Cancer Awareness Month is observed every year in the month of November. It intends to educate public about signs and symptoms of lung cancer. Creating [...]
Comments Off on New Lung Cancer Treatment Approved By NHS Scotland
The Scottish Medicines Consortium (SMC) confirms another immunotherapy treatment in combination with chemotherapy drugs is to be made available on NHS for [...]
Comments Off on New Study Could Help in Personalizing Lung Cancer Treatment
Researchers at the University of Copenhagen have used highly sophisticated molecular analyzes for the purpose of identifying key proteins that signal pathways [...]